Journal of Diabetes Research

Journal of Diabetes Research / 2017 / Article

Corrigendum | Open Access

Volume 2017 |Article ID 7072538 | 2 pages | https://doi.org/10.1155/2017/7072538

Corrigendum to “Optimal Hemoglobin A1c Levels for Screening of Diabetes and Prediabetes in the Japanese Population”

Received26 Jul 2017
Accepted14 Aug 2017
Published24 Sep 2017

In the article titled “Optimal Hemoglobin A1c Levels for Screening of Diabetes and Prediabetes in the Japanese Population” [1], there were errors in Table 3 and Figure 1, which are corrected as follows.


HbA1c (%)Youden’s indexSensitivity (%)Specificity (%)Positive predictive value (%)Negative predictive value (%)Positive likelihood ratioNegative likelihood ratioAccuracy

≧5.60.39994.245.710.499.21.70.148.8
≧5.70.53594.259.313.399.32.30.161.5
≧5.80.62591.970.617.399.23.10.171.9
≧5.90.68588.480.223.099.04.50.180.7
≧6.00.71483.787.631.298.86.80.287.4
≧6.10.66069.896.355.697.918.70.394.6
≧6.20.62765.197.664.497.727.00.495.6
≧6.30.55757.098.774.297.243.10.496.1
≧6.40.52653.599.179.397.057.30.596.2
≧6.50.44945.399.586.796.590.60.596.1

References

  1. M. Shimodaira, S. Okaniwa, N. Hanyu, and T. Nakayama, “Optimal hemoglobin A1c levels for screening of diabetes and prediabetes in the Japanese population,” Journal of Diabetes Research, vol. 2015, Article ID 932057, 6 pages, 2015. View at: Publisher Site | Google Scholar

Copyright © 2017 Masanori Shimodaira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

528 Views | 204 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.